A Phase III Randomized Multicenter Study,Comparing an Induction Chemotherapy Followed by Irradiation and Concurrent Erbitux Versus Chemoradiotherapy for Patients With Locoregional Advanced Head and Neck Cancers.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2018
At a glance
- Drugs Cetuximab (Primary) ; Docetaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 17 Jul 2018 Results published in the Journal of Clinical Oncology
- 25 Oct 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2018.
- 06 Jun 2017 Results assessing the impact of p16 expression on the treatment outcome in oropharyngeal cancers patients (n=172), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology